EAT-DUTA AndroCoV Trial

NCT04729491 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Dutasteride 0.5 mg
DRUG: Azithromycin
DRUG: Nitazoxanide
DRUG: Placebo

Sponsor

Corpometria Institute